ARWR
ARROWHEAD PHARMA
Health Care·Biotechnology·UNITED STATES
$78.89
MCap $11.1B
as of 2026-06-26
Total
C1w
Fund
D1w
Quant
A1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-27
MIDOS SI
-0.49
Sentiment 81.0%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$78.89
Adaptive Mean
$80.47
-1.58 vs mean
Adaptive σ
1.62
MIDOS BB
$77.23 – $83.70
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
-0.15
ROE
-46.4%
Z -0.54
Rev Gr
-86.4%
Z -0.98
EPS Gr
99.8%
Z +0.31
OPM Gr
—
Z —
FCF Yld
-0.5%
Z +0.05
EPS Surp
14.9%
Z +0.06
EPS 3mo Δ
2.7%
Z +0.21
Fwd P/E
-18.19
Z —
PEGY
-0.18
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-27
Q3M
2.50
Q6M
1.85
Q12M
12.41
MA 30/100
1.113
Bullish (MA30 > MA100)
α (Jensen)
0.2512
β (12M)
1.62
σ (12M)
0.653
Divergence — Fundamentals vs Momentum
Z Percentile
24%
Q Percentile
99%
Divergence
-75.4
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
10.1
RS Pctl
64%
RS Decile
D7
Persistence
1w
at grade C
Options / OI Analysis
as of 2026-06-27
OI Center
$79.27
+0.5% from spot
Max Pain
$75.00
PCR (OI)
0.36
contrarian_bearish
Skew
-0.12
OI Composite
-1
neutral
Direction
neutral